Abstract
Chronic subdural hematoma (CSDH) is defined as a collection of blood in the subdural space for more than 21 days. The most common cause of CSDH is trauma, which is usually considered as a minor trauma. Dementia, coagulation defects, heavy alcohol use, infancy, and age are major risk factors for the development of CSDH. On the other hand, electroconvulsive therapy (ECT) is not among the major risk factors, but there are several case reports of CSDH following ECT reported in the literature. Based on these reported cases, clinicians should consider the possibility of CSDH in high-risk psychiatric patients during and after ECT.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
American Psychiatric Association. The practice of electroconvulsive therapy: recommendations for treatment, training, and privileging. Washington, DC: APA Press; 1990.
American Psychiatric Association. The practice of electroconvulsive therapy. Recommendations for treatment, training, and privileging: a task force report of APA. Washington, DC: American Psychiatric Association; 2002.
Andrade C, Arumugham SS, Thirthalli J. Adverse effects of electroconvulsive therapy. Psychiatr Clin North Am. 2016;39:513–30.
Andrade C, Bolwig TG. Electroconvulsive therapy, hypertensive surge, blood-brain barrier breach, and amnesia: exploring the evidence for a connection. J ECT. 2014;30:160–4.
Anwar N, Brakoulias V. Safety of electroconvulsivetherapy after subdural hemorrhage. Aust N Z J Psychiatry. 2010;44:294.
Awasthy N, Chand K. Subdural hematoma: as complication of electroconvulsive therapy. Pak J Med Sci. 2005;21:491–3.
Bryson EO, Kellner CH. Chronic subdural hematoma following electroconvulsive therapy. Indian J Psychol Med. 2013;35:220.
Bleich S, Degner D, Scheschonka A, Ruther E, Kropp S. Electroconvulsive therapy and anticoagulation [letter]. Can J Psychiatry. 2000;45:87–8.
Cristancho MA, Alici Y, Augoustides JG, O’Reardon JP. Uncommon but serious complications associated with electroconvulsive therapy: recognition and management for the clinician. Curr Psychiatry Rep. 2008;10:474–80.
Dauleac C, Vinckier F, Bourdillon P. Subdural hematoma and electroconvulsive therapy: a case report and review of the literature. Neurochirurgie. 2019;65:40–2.
Dennis NM, Dennis PA, Shafer A, Weiner RD, Husain MM. Electroconvulsive therapy and all-cause mortality in Texas, 1998-2013. J ECT. 2017;33:22–5.
Hsiao JK, Evans DL. ECT in a depressed patient after craniotomy. Am J Psychiatry. 1984;141:442–4.
Kulkarni RR, Melkundi S. Subdural hematoma: an adverse event of electroconvulsive therapy case report and literature review. Case Rep Psychiatry. 2012;2012:585303.
Liff JM, Bryson EO, Maloutas E, Garruto K, Pasculli RM, Briggs MC, Kellner CH. Transient hemiparesis (Todd’s paralysis) after electroconvulsive therapy (ECT) in a patient with major depressive disorder. J ECT. 2013;29:247–8.
Malek-Ahmadi P, Beceiro JR, McNeil BW, Weddige RL. Electroconvulsive therapy and chronic subdural hematoma. Convuls Ther. 1990;6:38–41.
Mehta V, Mueller PS, Gonzalez-Arriaza HL, Pankratz VS, Rummans TA. Safety of electroconvulsive therapy in patients receiving long-term warfarin therapy. Mayo Clin Proc. 2004;79:1396–401.
Nordanskog P, Dahlstrand U, Larsson MR, Larsson EM, Knutsson L, Johanson A. Increase in hippocampal volume after electroconvulsive therapy in patients with depression: a volumetric magnetic resonance imaging study. J ECT. 2010;26:62–7.
Rocha RB, Dondossola ER, Grande AJ, Colonetti T, Ceretta LB, Passos IC, Quevedo J, da Rosa MI. Increased BDNF levels after electroconvulsive therapy in patients with major depressive disorder: a meta-analysis study. J Psychiatr Res. 2016;83:47–53.
Sackeim HA, Prudic J, Devanand DP, Kiersky JE, Fitzsimons L, Moody BJ, McElhiney MC, Coleman EA, Settembrino JM. Effects of stimulus intensity and electrode placement on the efficacy and cognitive effects of electroconvulsive therapy. N Engl J Med. 1993;328:839–46.
Sadock, Sadock VA. Kaplan & Sadock’s comprehensive textbook of psychiatry. Philadelphia: Lippincott Williams & Wilkins; 2009.
Saha D, Bisui B, Thakurta RG, Ghoshmaulik S, Singh OP. Chronic subdural hematoma following electroconvulsive therapy. Indian J Psychol Med. 2012;34:181–3.
Swartz CM, Nelson AI. Rational electroconvulsive therapy electrode placement. Psychiatry (Edgmont). 2005;2:37–43.
Taylor S. Electroconvulsive therapy: a review of history, patient selection, technique, and medication management. South Med J. 2007;100:494–8.
Tzabazis A, Schmitt HJ, Ihmsen H, Schmidtlein M, Zimmermann R, Wielopolski J, Münster T. Postictal agitation after electroconvulsive therapy: incidence, severity, and propofol as a treatment option. J ECT. 2013;29:189–95.
UK ECT Review Group. Efficacy and safety of electroconvulsive therapy in depressive disorders: a systematic review and meta-analysis. Lancet. 2003;361:799–808.
Uno M, Toi H, Hirai S. Chronic subdural hematoma in elderly patients: is this disease benign? Neurol Med Chir (Tokyo). 2017;57:402–9.
Wijeratne C, Shome S. Electroconvulsive therapy and subdural hemorrhage. J ECT. 1999;15:275–9.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Kalyoncu, A., Gonul, A.S., Turgut, M. (2021). Chronic Subdural Hematoma Following Electroconvulsive Therapy: A Rare but Serious Complication. In: Turgut, M., Akhaddar, A., Hall, W.A., Turgut, A.T. (eds) Subdural Hematoma. Springer, Cham. https://doi.org/10.1007/978-3-030-79371-5_20
Download citation
DOI: https://doi.org/10.1007/978-3-030-79371-5_20
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-79370-8
Online ISBN: 978-3-030-79371-5
eBook Packages: MedicineMedicine (R0)